{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:55:10Z","timestamp":1765443310412,"version":"3.46.0"},"reference-count":24,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2025.2910","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:52:31Z","timestamp":1761555151000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of ductal carcinoma\n                    <i>in situ<\/i>\n                    coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes"],"prefix":"10.3892","volume":"24","author":[{"given":"Neslihan","family":"Fedai","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara 06230, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilgin","family":"Koc","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hacettepe University, School of Medicine, Ankara 06230, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gozde","family":"Kavgaci","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hacettepe University, School of Medicine, Ankara 06230, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Uner","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hacettepe University, School of Medicine, Ankara 06230, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Uner","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hacettepe University, School of Medicine, Ankara 06230, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sercan","family":"Aksoy","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hacettepe University, School of Medicine, Ankara 06230, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neyran","family":"Kertmen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hacettepe University, School of Medicine, Ankara 06230, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"key20251211105201_b1-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20251211105201_b2-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20251211105201_b3-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"Li","year":"2005","journal-title":"Br J Cancer"},{"key":"key20251211105201_b4-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.pathol.4.110807.092306","article-title":"Preinvasive breast cancer","volume":"5","author":"Sgroi","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"key20251211105201_b5-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc2950","article-title":"What is the malignant nature of human ductal carcinoma in situ?","volume":"11","author":"Espina","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20251211105201_b6-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.surg.2009.06.039","article-title":"Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?","volume":"146","author":"Chagpar","year":"2009","journal-title":"Surgery"},{"key":"key20251211105201_b7-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.bjc.6605655","article-title":"Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer","volume":"102","author":"Wong","year":"2010","journal-title":"Br J Cancer"},{"issue":"9934","key":"key20251211105201_b8-MCO-24-1-02910","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46309-2","article-title":"Overall survival is improved when DCIS accompanies invasive breast cancer","volume":"9","author":"Kole","year":"2019","journal-title":"Sci Rep"},{"key":"key20251211105201_b9-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molonc.2013.07.005","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: Revisited","volume":"7","author":"Cowell","year":"2013","journal-title":"Mol Oncol"},{"key":"key20251211105201_b10-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.celrep.2016.06.051","article-title":"Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer","volume":"16","author":"Lesurf","year":"2016","journal-title":"Cell Rep"},{"issue":"484","key":"key20251211105201_b11-MCO-24-1-02910","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.08.16","article-title":"The prognostic significance of co-existence ductal carcinoma in situ in invasive ductal breast cancer: A large population-based study and a matched case-control analysis","volume":"7","author":"Chen","year":"2019","journal-title":"Ann Transl Med"},{"key":"key20251211105201_b12-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.immuni.2013.07.008","article-title":"The continuum of cancer immunosurveillance: Prognostic, predictive, and mechanistic signatures","volume":"39","author":"Galon","year":"2013","journal-title":"Immunity"},{"key":"key20251211105201_b13-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-030-91311-3_3","article-title":"Tumor-infiltrating lymphocytes and their role in solid tumor progression","volume":"113","author":"Whiteside","year":"2022","journal-title":"Exp Suppl"},{"key":"key20251211105201_b14-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.21873\/anticanres.11997","article-title":"Using TILs to predict therapeutic effect of chemotherapy (Pertuzumab, Trastuzumab, Docetaxel) on HER2-positive breast cancer","volume":"37","author":"Kashiwagi","year":"2017","journal-title":"Anticancer Res"},{"key":"key20251211105201_b15-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: A pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"key":"key20251211105201_b16-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3322\/caac.21393","article-title":"Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"key20251211105201_b17-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2147\/CMAR.S185212","article-title":"Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: A Surveillance, Epidemiology and End Results (SEER) Analysis","volume":"11","author":"Shao","year":"2019","journal-title":"Cancer Manag Res"},{"key":"key20251211105201_b18-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijsu.2019.01.016","article-title":"Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study","volume":"63","author":"Lopez Gordo","year":"2019","journal-title":"Int J Surg"},{"key":"key20251211105201_b19-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00432-019-02930-2","article-title":"Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC\/DCIS) versus pure invasive ductal carcinoma (IDC): A comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes","volume":"145","author":"Goh","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"103781","key":"key20251211105201_b20-MCO-24-1-02910","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2025.103781","article-title":"Does the presence of ductal carcinoma in situ affect prognostic outcomes after neoadjuvant therapy in invasive ductal carcinoma of the breast?","volume":"40","author":"Zhou","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key20251211105201_b21-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"11181","DOI":"10.1007\/s00432-023-04895-9","article-title":"Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ","volume":"149","author":"Liu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1164","key":"key20251211105201_b22-MCO-24-1-02910","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041164","article-title":"Clinical significance of tumour-infiltrating B lymphocytes (TIL-Bs) in breast cancer: A systematic literature review","volume":"15","author":"Lam","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20251211105201_b23-MCO-24-1-02910","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/annonc\/mdu112","article-title":"Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: Results from the FinHER trial","volume":"25","author":"Loi","year":"2014","journal-title":"Ann Oncol"},{"issue":"2527","key":"key20251211105201_b24-MCO-24-1-02910","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12102527","article-title":"Prognostic value of tumour-infiltrating lymphocytes in an unselected cohort of breast cancer patients","volume":"12","author":"Sch\u00fcler","year":"2022","journal-title":"Diagnostics (Basel)"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:52:08Z","timestamp":1765443128000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2025.2910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,27]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2025.2910","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"type":"print","value":"2049-9450"},{"type":"electronic","value":"2049-9469"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}